|
0
|
|
ACE2 decoy Fc-fusions and bispecific killer engagers require Fc engagement for in vivo efficacy against SARS-CoV-2.
(academic.oup.com)
|
Dick JK
…
Hart GT
Journal of Immunology
2026-08-04
|
#covid-19
#antibody
#immunotherapy
#therapeutics
#viral evolution
|
|
0
|
|
Association of probiotic use with nivolumab efficacy in gastric cancer patients on gastric acid suppressants.
(linkinghub.elsevier.com)
|
Yamaguchi M
…
Ohtani H
iScience
2026-08-04
|
#immunotherapy
#gastric cancer
#microbiome
#probiotic
|
|
0
|
|
Immunotherapy of malignant melanoma using T cell-activating microbeads.
(academic.oup.com)
|
Hassan NT
…
Beyersdorf N
Journal of Immunology
2026-08-04
|
#immunotherapy
#melanoma
#t-cells
#checkpoint-inhibitors
#cytotoxicity
|
|
0
|
|
Enforcing mTORC1 activity in therapeutic CD4+ T cells promotes persistence but eventual immune exhaustion.
(academic.oup.com)
|
Sillito F
…
Chakraverty R
Journal of Immunology
2026-08-04
|
#immunotherapy
#t cell
#metabolism
#exhaustion
#engineering
|
|
0
|
|
Tunable universal OR-gated CAR T cells for AML.
(linkinghub.elsevier.com)
|
Siddiqui MY
…
Wong WW
iScience
2026-08-04
|
#car-t
#leukemia
#immunotherapy
#synthetic biology
#antigen
|
|
0
|
|
Fluid shear stress as a co-stimulatory cue to enhance T cell priming and restore activation in cancer patient T cells.
(academic.oup.com)
|
Sarna NS
…
King MR
Journal of Immunology
2026-08-04
|
#mechanotransduction
#immunotherapy
#t cell
#cancer
#activation
|
|
0
|
|
Iparomlimab and tuvonralimab in previously treated patients with cervical cancer.
(linkinghub.elsevier.com)
|
Lou H
…
Liu J
Cell Reports Medicine
2026-08-04
|
#clinical trial
#immunotherapy
#cervical cancer
#oncology
#checkpoint-inhibitors
|
|
0
|
|
Targeting peripheral 5-HT(2A)R enhances antitumor immunity in colorectal cancer.
(linkinghub.elsevier.com)
|
Wen Y
…
Chen J
Cell
2026-08-04
|
#immunotherapy
#colorectal cancer
#immunity
#t cell
#drug development
|
|
0
|
|
CCR7(+) activated dendritic cells are essential for spontaneous and immunotherapy-driven anti-tumor immunity.
(linkinghub.elsevier.com)
|
Koufaki MA
…
Zelenay S
Immunity
2026-08-04
|
#immunotherapy
#tumor immunity
#dendritic cell
#transcriptomics
#t cell activation
|
|
0
|
|
Antigen presentation requirements for effective cDC1-based cancer immunotherapy.
(academic.oup.com)
|
Pineda JE
…
Gubin MM
Journal of Immunology
2026-08-04
|
#cancer
#immunotherapy
#dendritic cell
#vaccination
#antigen-presentation
|